|
Originally published In Press as doi:10.1074/jbc.C200381200 on July 18, 2002
J. Biol. Chem., Vol. 277, Issue 36, 32417-32420, September 6, 2002
ACCELERATED PUBLICATION
The Drosophila melanogaster brainiac Protein Is a
Glycolipid-specific
1,3N-Acetylglucosaminyltransferase*
Reto
Müller,
Friedrich
Altmann ,
Dapeng
Zhou§, and
Thierry
Hennet¶
From the Institute of Physiology, University of Zürich,
Winterthurerstrasse 190, 8057 Zürich, Switzerland and the
Institute of Chemistry, Universität für
Bodenkultur, Muthgasse 18, A-1190 Wien, Austria
Received for publication, June 26, 2002
 |
ABSTRACT |
Mutations at the Drosophila melanogaster
brainiac locus lead to defective formation of the follicular
epithelium during oogenesis and to neural hyperplasia. The
brainiac gene encodes a type II transmembrane protein
structurally similar to mammalian 1,3-glycosyltransferases. We have
cloned the brainiac gene from D. melanogaster
genomic DNA and expressed it as a FLAG-tagged recombinant protein in
Sf9 insect cells. Glycosyltransferase assays showed that
brainiac is capable of transferring
N-acetylglucosamine (GlcNAc) to -linked mannose (Man),
with a marked preference for the disaccharide Man( 1,4)Glc, the core
of arthro-series glycolipids. The activity of brainiac toward arthro-series glycolipids was confirmed by showing that the enzyme efficiently utilized glycolipids from insects as acceptors whereas it did not with glycolipids from mammalian cells. Methylation analysis of the brainiac reaction product
revealed a 1,3 linkage between GlcNAc and Man, proving that
brainiac is a 1,3GlcNAc-transferase. Human
1,3GlcNAc-transferases structurally related to
brainiac were unable to transfer GlcNAc to
Man( 1,4)Glc-based acceptor substrates and failed to rescue a
homozygous lethal brainiac allele, indicating that these
proteins are paralogous and not orthologous to
brainiac.
 |
INTRODUCTION |
The importance of glycoconjugates in regulating developmental
processes is continually being supported by studies performed in
various model organisms like Caenorhabditis elegans (1), Drosophila melanogaster (2), and the mouse (3). The
Drosophila genes sugarless,
sulfateless, pipe, tout-velu, and
dally participate in the formation of proteoglycans. Loss of
function mutations in some of these genes produce polarity phenotypes
mechanistically connected to incorrect diffusion of the signaling
proteins wingless and hedgehog (4-6). The
rotated abdomen locus, whose disruption is associated with a
helical rotation of the body, has been found to encode a potential
O-mannosyltransferase (7), and fringe, which
modulates the interaction of the Notch receptor with its ligands (8), has recently been demonstrated to be a
1,3N-acetylglucosaminyltransferase (GlcNAcT)1 (9, 10).
The Drosophila gene brainiac (brn)
(11) encodes a protein that shares structural motifs with
1,3glycosyltransferases (12, 13). The brn gene is
localized on the X chromosome. brn was shown to cooperate
with the epidermal growth factor receptor and one of its ligands, the
Drosophila TGF homologue gurken (11) during
oogenesis. Mutant brn alleles exhibit altered morphology of
the follicular epithelium (11), female sterility (14), and germ line
loss (15). Furthermore, brn embryos develop neural hyperplasia and epidermal hypoplasia (11) as encountered with Notch hypomorphic alleles and other neurogenic mutants,
suggesting implications of brn in Notch signaling
(16, 17).
While the relationships between brn and specific signaling
pathways have been examined genetically, the nature of these
interactions remained elusive as long as the biochemical function of
brn was unclear. In the present study, we show that
brn has a 1,3N-acetylglucosaminyltransferase (GlcNAcT) activity directed toward the Man( 1,4)Glc core structure of
arthro-series glycolipids.
 |
EXPERIMENTAL PROCEDURES |
Cloning and Expression--
The brn gene was
amplified by PCR from D. melanogaster OregonR genomic DNA
during 30 cycles at 95 °C for 45 s, 55 °C for 30 s, 72 °C for 60 s using the primers
5'-TTTGGATCCGTCGCCATGCAAAGT-3' and 5'-CCTGTTCTAGATGCTACGCGTAAT-3'.
The resulting 1.0-kb fragment was digested with BamHI
and XbaI and subcloned into the pFastbac-FLAG(a) vector
(Invitrogen) linearized at the BamHI and
XbaI sites. The FLAG-tagged brn gene was
expressed as a recombinant baculovirus in insect cells as described
previously (13). Infected cells (107) were lysed at 72 h post-infection in 600 µl of 50 mM Tris/HCl, pH 7.4, 150 mM NaCl, 1% Triton X-100, and a protein inhibitor mixture
(complete, EDTA free, Roche Diagnostics) on ice.
Post-nuclear supernatants were incubated with 240 µl of anti-FLAG
M2-agarose beads (Sigma) under rotation for 2.5 h at 4 °C.
Beads were washed three times with Tris-buffered saline and used as
enzyme source for assays.
Glycosyltransferase Assays--
All donor and acceptor
substrates were from Sigma except Man( 1,4)Glc( 1-OpNP) (pNP = p-nitrophenyl), which was purchased from Toronto Research
(North York, Canada). Glycosyltransferase activity was assayed for 60 min at 25 °C with 15 µl of beads, 5% Me2SO, 20 mM MnCl2, 0.08 mM UDP-GlcNAc
including 5 × 104 cpm of
UDP-[14C]GlcNAc (Amersham Biosciences), and
various acceptors (see Table I). Reaction products were purified over
C18 Sep-Pak cartridges (Waters) (18) and quantified in a
Tri-Carb 2900TR liquid scintillation counter (Packard) with
luminescence correction.
Glycolipid Extraction--
D. melanogaster Schneider
2 cells, Spodoptera frugiperda Sf9 cells, and human
colon carcinoma Caco-2 cells were washed three times in
phosphate-buffered saline and extracted in
isopropanol:hexane:H2O (55:25:20). Extracts were spun twice
at 500 x g, and supernatants were dried under
N2. Phospholipids were removed by saponification in 0.2 M NaOH in methanol for 24 h at 37 °C. After
neutralization with HCl, the extracts were expanded to theoretical
upper phase (methanol:water:chloroform, 47:48:3), applied on
C18 SepPak cartridges, and eluted with 5 ml of methanol.
Eluates were dried under N2 and resuspended in 500 µl of
methanol. The procedure yielded about 120 µg of mannose equivalents
for 108 S2 and Sf9 cells and 20 µg of mannose
equivalents from 107 Caco-2 cells as determined by the
phenol sulfuric acid assay (19).
Thin-layer Chromatography (TLC)--
Glycolipids (5 µg of
mannose equivalents per assay) were dried under N2 and
incubated together with 10 µl of beads-bound enzyme in 50 µl of 50 mM cacodylate buffer, pH 7.1, 20 mM
MnCl2, 0.06% Triton X-100, 2.5 × 104 cpm
of UDP-[14C]GlcNAc for 90 min at 25 °C. Reaction
products were expanded to theoretical upper phase and purified over
C18 Sep-Pak cartridges as described above. After drying
over N2, the eluates were taken up in 100 µl of
methanol:chloroform (1:1) and separated on aluminum high-performance
thin-layer chromatography plates (Merck, Darmstadt, Germany) using a
solvent system of chloroform:methanol:0.25% CaCl2 (5:4:1).
Plates were stained with orcinol sulfuric acid (Sigma). The
[14C]GlcNAc( 1,3)Gal( 1,4)Glc-ceramide (Lc3) standard
was produced enzymatically with the Lc3 synthase 1,3 GlcNacT protein
(20) using Gal( 1,4)Glc-ceramide (Lc2) (Sigma) as acceptor substrate.
brn Complementation in Drosophila--
Human 3GnT1 (21),
3GnT4 (22) and 3GnT5 (20) cDNAs and the Drosophila
brn gene were subcloned into the pUAST vector (23). The rescue
constructs pUAST- 3GnT1, pUAST- 3GnT4, pUAST- 3GnT5, and
pUAST-brn were injected together with the pUChsp 2-3
P-element helper plasmid (Flybase accession FBmc0000938) into
yellow white Drosophila embryos using standard procedures.
Then, white+ progeny was selected and
X-chromosomal insertions of the transgene excluded. The GAL4 lines,
driving ubiquitous expression of the UAS-transgenes in an
armadillo pattern (24), carry Bloomington Stock numbers 1560 and 1561. Males of the genotype yellow white/Y; transgene/+
were mated to virgins forked
brn1.6P6/FM6-w1; 1560 GAL4/+ and forked
brn1.6P6/FM6-w1; 1561 GAL4/+ and the progeny
examined for males carrying the forked mutation for 8 days
after eclosion of the first flies. At least two independent lines of
each transgene were used for the complementation assay, which were
repeated four times.
Structural Analysis--
A mixture of substrate and of 10 nmol
of product was separated by reversed phase HPLC on a 3 × 250 mm
column filled with 5 µM ODS Hypersil (Shandon) at a flow
rate of 0.6 ml/min. The column was eluted with a linear gradient from 6 to 24% of methanol during 18 min in 0.1 M ammonium
acetate, pH 4.0. p-Nitrophenylglycosides were monitored at
245 nm. The mixture was also analyzed after incubation with
N-acetyl- -hexosaminidase from jack beans (Sigma) (25).
The fraction of interest was collected in a screw capped glass vial and
dried in a speed-vac concentrator. A small aliquot was used for matrix
assisted laser desorption mass spectrometry as described elsewhere
(25). The sample was dried over phosphorus pentoxide in
vacuo and permethylated using NaOH (26). Partially permethylated
alditol acetates were prepared using NaBD4 as the reducing
agent and analyzed by gas chromatography/mass spectrometry using a
60 m SP2330 (Restek) (27) and a Finnigan Ion Trap ITD800. Derivatives of terminal and 3-substituted galactose served to compare
retention times with the data given by Doares et al.
(27).
 |
RESULTS |
We have cloned the D. melanogaster brn gene by PCR
amplification and expressed it as an N-terminally FLAG-tagged
full-length protein in Sf9 insect cells. The recombinant
brn protein was bound to anti-FLAG-agarose beads, and
cellular contaminants such as possible endogenous acceptor substrates
were washed out before assaying for enzymatic activity. A GlcNAcT
activity was only detected toward the Man( 1-OpNP) acceptor when
monosaccharide substrates were assayed (Table
I). Highest activity was measured toward the disaccharide acceptor Man( 1,4)Glc( 1-OpNP), whereas a slight activity was also detected toward Gal( 1,4)Glc( 1-OpNP) (Table I).
The Man( 1,4)Glc structure represents the core of arthro-series glycolipids found in nematodes (28) and insects (29) among others.
In Drosophila, the arthro-series Man( 1,4)Glc core is
elongated with a 1,3-linked GlcNAc (30), suggesting that
brn may represent the enzyme catalyzing this step. To test
this hypothesis, we have isolated neutral glycolipids from
Drosophila S2 and Spodoptera Sf9 cells and
assayed these glycolipids as acceptors for the anti-FLAG beads-bound
brn enzyme. A significant GlcNAc-transferase activity was
detected when incubating brn together with insect
glycolipids, whereas only a low activity was measured with glycolipids
extracted from mammalian Caco-2 cells, likely reflecting the low
specificity of brn for lactosylceramide. The reaction
products were separated by TLC and plates were autoradiographed,
revealing a [14C]GlcNAc-labeled band at the size of a
trihexoside ceramide in S2 and Sf9 cells (Fig.
1).

View larger version (114K):
[in this window]
[in a new window]
|
Fig. 1.
TLC separation of
brn-modified glycolipids. The top
panel shows a plate stained with orcinol reagent and the
bottom panel the autoradiogram of the same plate.
brn-bound beads (brn) or beads preincubated with
mock-infected Sf9 cells (mock) were incubated with
neutral glycolipids from Drosophila S2 cells (S2),
Spodoptera Sf9 cells (Sf9), human
Caco-2 cells (Caco), or without added glycolipids (no
GL). The neutral glycolipid standard (GL Std)
contained: Gal-Cer; Gal( 1,4)Glc-Cer (Lc2);
Gal( 1,4)Gal( 1,4)Glc-Cer (Gb3);
Gal( 1,4)Gal( 1,4)Glc-Cer (Gb4), and
GalNAc( 1,3)GalNAc( 1,3)Gal( 1,4)Glc-Cer (FS).
Lc2/Lc3, Lc2 was elongated to Lc3 by
incorporation of [14C] GlcNAc catalyzed by the human
3GnT-V enzyme (20).
|
|
The nature of the linkage between GlcNAc and the underlying -linked
Man residue was investigated by methylation analysis of the
brn reaction product GlcNAc-Man( 1-OpNP). In reversed
phase HPLC, the presumed disaccharide product eluted slightly ahead of
the substrate Man( 1-OpNP). The disaccharide peak disappeared upon
incubation with N-acetyl- -hexosaminidase (Fig.
2A). The purified fraction
corresponding to the disaccharide peak exhibited a pseudomolecular ion
of m/z 513.5. Linkage analysis of the
GlcNAc-Man( 1-OpNP) disaccharide product gave a peak at the
relative retention time of 0.597, which suggests a 2- or a
3-substituted mannosyl residue (27). The fragment spectrum clearly
identified the derivative as substituted in the 3-position (Fig.
2B), thus confirming the identity of brn as a
1,3 GlcNAcT.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 2.
Structural analysis of brn
product. A, HPLC separation of product and
substrate of 1,3GlcNAcT brn.
p-Nitrophenyl- -D-mannopyranoside was
incubated with brn in the presence of UDP-GlcNAc. The
mixture was prepurified over Sep-Pak C18 cartridges and
subjected to reversed phase chromatography (trace a). A
small product peak (P) eluted ahead of the substrate
(S). The product disappeared upon incubation with
-N-acetylhexosaminidase (trace b) which
indicates it to contain a -linked GlcNAc residue. B,
methylation analysis of p-nitrophenyl disaccharide. The
electron impact mass spectrum of the partially methylated
monodeuterated alditol acetate derived from the mannosyl residue of the
disaccharide product shows several fragments indicative of a
substitution in position 3 as depicted by the insert. Especially the
presence of mass 118 and the absence of mass 190 exclude a
2-substitution, which could not be ruled out from the retention time
alone (27).
|
|
The brn protein is structurally related to human 1,3
glycosyltransferase enzymes (12, 13). The acceptor specificity of brn for the arthro-series glycolipid core suggested that it
represents a paralogous enzyme to the mammalian 1,3
glycosyltransferases, including 1,3 galactosyltransferases (13, 31,
32), 1,3 GlcNAcT (20, 22), and a
1,3-N-acetylgalactosaminyltransferase (33) acting on
GlcNAc -, Gal -, and GalNAc -based acceptors. Although no
mammalian 1,3 GlcNAcT has been described to act on -linked Man
acceptors, we have investigated whether the three human 1,3 GlcNAcT
structurally closest to brn can complement the lethal
phenotype of brn deficient Drosophila flies. To
this end, we have expressed the human 3GnT-I (21), -IV (22), and -V
(20) in brn1.6P6 mutant flies (34) using the
UAS-GAL4 transgenesis system (23).
The human 3GnT transgenes and a brn transgene were
expressed in flies carrying the allele brn1.6P6,
which causes lethality at the late pupal stage. The transgenes were
expressed ubiquitously using armadillo GAL4 transactivator lines. The brn transgene did rescue
brn1.6P6 mutant males from their hemizygous late
pupal lethality, whereas the human 3GnT transgenes did not (Table
II). The rescue of
brn1.6P6 males was confirmed by detection of the
forked marker, whose gene is located besides the
brn1.6P6 allele on the X chromosome. Control crosses
of females carrying brn1.6P6 with yellow
white males did not yield any living brn1.6P6
forked/Y males either. The inability of human 3GnT
enzymes to compensate for the loss of brn activity in mutant
flies suggested that the former enzymes cannot elongate the
arthro-series glycolipid core in vivo. This was confirmed
in vitro by showing that the human 3GnT enzymes did not
exhibit significant activity toward the Man( 1,4)Glc( 1-OpNP)
acceptor (Table II).
View this table:
[in this window]
[in a new window]
|
Table II
Complementation of Drosophila brn1.6P6
Rescue of the brn1.6P6 late pupal lethal phenotype
by ubiquitous expression of Drosophila brn and human
1,3GlcNAcT transgenes.
|
|
 |
DISCUSSION |
We have shown that Drosophila brn, a member of the
1,3 glycosyltransferase family, encodes a 1,3 GlcNAcT enzyme with
a specificity for the Man( 1,4)Glc disaccharide found in
arthro-series glycolipids (29). Several mammalian enzymes structurally
related to brn have been suggested to represent homologues
(35-37). However, the specificity of brn for
Man( 1,4)Glc, a disaccharide that has never been described in
vertebrates, rather indicates that brn and mammalian 1,3
glycosyltransferases are paralogous proteins derived from a common
ancestor gene.
The functional disparity between the 1,3 GlcNAcT brn and
mammalian 1,3 GlcNAcT enzymes is further supported by the inability of the latter to complement the lethal phenotype of the mutant allele
brn1.6P6 in Drosophila. The specificity
of brn toward Man 1,4Glc-Cer suggests the presence of
functional homologues only in organisms harboring arthro-series
glycolipids, whose core structure is GlcNAc( 1,3)Man( 1,4)Glc-Cer. A protein structurally related to brn has recently been
described in C. elegans (38), which express arthro-series
glycolipids (28). The loss of that gene, named bre-5 (39),
renders the animal resistant to high doses of Bacillus
thuringiensis Bt toxin. Since Bt toxin binds to arthro-series
glycolipids (40), it is possible that bre-5 participates in
the formation of this class of glycolipids in C. elegans and
thereby represents a true orthologue of brn.
brn mutations affect follicle cell-germ line interactions
and lead to neurogenic phenotypes in Drosophila embryos.
Considering the involvement of brn in glycolipid
biosynthesis, one can envision that arthro-series glycolipids may
regulate cell adhesion, proliferation, and differentiation via
carbohydrate-lectin interactions. On the other hand, arthro-series
glycolipids may modulate specific signaling proteins in a way similar
to gangliosides affecting the epidermal growth factor receptor (41,
42), insulin receptor (43), and platelet-derived growth factor receptor
(44) signaling cascades. The notion that brn glycolipid
products interact with adhesion or signaling proteins implies that
other mutant genes with phenotypes similar to those encountered in
brn mutant flies may encode partner lectin/signaling
proteins. Along this line, Drosophila egghead mutants have
similar and non-additive phenotypes to brn (17). Experiments
aimed at characterizing the biochemical and functional relation between
brn products and the egghead protein should
reveal the mechanisms how arthro-series glycolipids regulate
morphogenic events during Drosophila development.
 |
ACKNOWLEDGEMENTS |
We thank Erich Frei, Michael Daube, and
Markus Noll from the Institute of Molecular Biology at the University
of Zürich for their assistance with the transgenic expression in
Drosophila.
 |
FOOTNOTES |
*
This work was supported by Swiss National Science Foundation
Grant 631-062662.00 (to T. H.).The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Present address: Dept. of Molecular Biology, Princeton University,
Washington Rd., Princeton, NJ 08544-1014.
¶
To whom correspondence should be addressed: Inst. of
Physiology, Winterthurerstrasse 190, 8057 Zurich, Switzerland. Tel.: 41-1-635-5080; Fax: 41-1-635-6814; E-mail:
thennet@access.unizh.ch.
Published, JBC Papers in Press, July 18, 2002, DOI 10.1074/jbc.C200381200
 |
ABBREVIATIONS |
The abbreviations used are:
GlcNAcT, N-acetylglucosaminyltransferase;
brn, brainiac;
TLC, thin-layer
chromatography;
pNP, p-nitrophenyl;
Cer, ceramide;
Lc2, Gal( 1,4)Glc-Cer;
Lc3, GlcNAc( 1,3)Gal( 1,4)Glc-Cer;
HPLC, high
performance liquid chromatography.
 |
REFERENCES |
| 1.
|
Herman, T.,
and Horvitz, H. R.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
974-979[Abstract/Free Full Text]
|
| 2.
|
Perrimon, N.,
and Bernfield, M.
(2000)
Nature
404,
725-728[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Hennet, T.,
and Ellies, L. G.
(1999)
Biochim. Biophys. Acta
1473,
123-136[Medline]
[Order article via Infotrieve]
|
| 4.
|
Sen, J.,
Goltz, J. S.,
Stevens, L.,
and Stein, D.
(1998)
Cell
95,
471-481[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Hacker, U.,
Lin, X.,
and Perrimon, N.
(1997)
Development (Camb.)
124,
3565-3573[Abstract]
|
| 6.
|
Bellaiche, Y.,
The, I.,
and Perrimon, N.
(1998)
Nature
394,
85-88[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Martin-Blanco, E.,
and Garcia-Bellido, A.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
6048-6052[Abstract/Free Full Text]
|
| 8.
|
Panin, V. M.,
Papayannopoulos, V.,
Wilson, R.,
and Irvine, K. D.
(1997)
Nature
387,
908-912[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Moloney, D. J.,
Panin, V. M.,
Johnston, S. H.,
Chen, J. H.,
Shao, L.,
Wilson, R.,
Wang, Y.,
Stanley, P.,
Irvine, K. D.,
Haltiwanger, R. S.,
and Vogt, T. F.
(2000)
Nature
406,
369-375[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Bruckner, K.,
Perez, L.,
Clausen, H.,
and Cohen, S.
(2000)
Nature
406,
411-415[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Goode, S.,
Wright, D.,
and Mahowald, A. P.
(1992)
Development (Camb.)
116,
177-192[Abstract]
|
| 12.
|
Yuan, Y. P.,
Schultz, J.,
Mlodzik, M.,
and Bork, P.
(1997)
Cell
88,
9-11[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Hennet, T.,
Dinter, A.,
Kuhnert, P.,
Mattu, T. S.,
Rudd, P. M.,
and Berger, E. G.
(1998)
J. Biol. Chem.
273,
58-65[Abstract/Free Full Text]
|
| 14.
|
Gans, M.,
Audit, C.,
and Masson, M.
(1975)
Genetics
81,
683-704[Abstract/Free Full Text]
|
| 15.
|
Swan, A.,
Hijal, S.,
Hilfiker, A.,
and Suter, B.
(2001)
Genome Res.
11,
67-77[Abstract/Free Full Text]
|
| 16.
|
Goode, S.,
and Perrimon, N.
(1997)
Cold Spring Harbor Symp. Quant. Biol.
62,
177-184[Abstract/Free Full Text]
|
| 17.
|
Goode, S.,
Melnick, M.,
Chou, T. B.,
and Perrimon, N.
(1996)
Development (Camb.)
122,
3863-3879[Abstract]
|
| 18.
|
Malissard, M.,
Borsig, L., Di,
Marco, S.,
Grutter, M. G.,
Kragl, U.,
Wandrey, C.,
and Berger, E. G.
(1996)
Eur. J. Biochem.
239,
340-348[Medline]
[Order article via Infotrieve]
|
| 19.
|
Dubois, M.,
Gilles, K. A.,
Hamilton, J. K.,
Rebers, P. A.,
and Smith, F.
(1956)
Anal. Chem.
28,
350-356[CrossRef]
|
| 20.
|
Henion, T. R.,
Zhou, D.,
Wolfer, D. P.,
Jungalwala, F. B.,
and Hennet, T.
(2001)
J. Biol. Chem.
276,
30261-30269[Abstract/Free Full Text]
|
| 21.
|
Zhou, D.,
Dinter, A.,
Gutierrez Gallego, R.,
Kamerling, J. P.,
Vliegenthart, J. F. G.,
Berger, E. G.,
and Hennet, T.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
406-411[Abstract/Free Full Text], correction (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 11673-11675
|
| 22.
|
Shiraishi, N.,
Natsume, A.,
Togayachi, A.,
Endo, T.,
Akashima, T.,
Yamada, Y.,
Imai, N.,
Nakagawa, S.,
Koizumi, S.,
Sekine, S.,
Narimatsu, H.,
and Sasaki, K.
(2001)
J. Biol. Chem.
276,
3498-3507[Abstract/Free Full Text]
|
| 23.
|
Brand, A. H.,
and Perrimon, N.
(1993)
Development (Camb.)
118,
401-415[Abstract]
|
| 24.
|
Sanson, B.,
White, P.,
and Vincent, J. P.
(1996)
Nature
383,
627-630[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Wilson, I. B.,
Zeleny, R.,
Kolarich, D.,
Staudacher, E.,
Stroop, C. J.,
Kamerling, J. P.,
and Altmann, F.
(2001)
Glycobiology
11,
261-274[Abstract/Free Full Text]
|
| 26.
|
Ciucanu, I.,
and Kerek, F.
(1984)
Carbohydr. Res.
131,
209-217[CrossRef]
|
| 27.
|
Doares, S. H.,
Albersheim, P.,
and Darvill, A. G.
(1991)
Carbohydr. Res.
210,
311-317[CrossRef]
|
| 28.
|
Gerdt, S.,
Lochnit, G.,
Dennis, R. D.,
and Geyer, R.
(1997)
Glycobiology
7,
265-275[Abstract/Free Full Text]
|
| 29.
|
Wiegandt, H.
(1992)
Biochim. Biophys. Acta
1123,
117-126[Medline]
[Order article via Infotrieve]
|
| 30.
|
Seppo, A.,
Moreland, M.,
Schweingruber, H.,
and Tiemeyer, M.
(2000)
Eur. J. Biochem.
267,
3549-3558[Medline]
[Order article via Infotrieve]
|
| 31.
|
Miyazaki, H.,
Fukumoto, S.,
Okada, M.,
Hasegawa, T.,
and Furukawa, K.
(1997)
J. Biol. Chem.
272,
24794-24799[Abstract/Free Full Text]
|
| 32.
|
Kolbinger, F.,
Streiff, M. B.,
and Katopodis, A. G.
(1998)
J. Biol. Chem.
273,
433-440[Abstract/Free Full Text]
|
| 33.
|
Okajima, T.,
Nakamura, Y.,
Uchikawa, M.,
Haslam, D. B.,
Numata, S. I.,
Furukawa, K.,
Urano, T.,
and Furukawa, K.
(2000)
J. Biol. Chem.
275,
40498-40503[Abstract/Free Full Text]
|
| 34.
|
Perrimon, N.,
Engstrom, L.,
and Mahowald, A. P.
(1989)
Genetics
121,
333-352[Abstract/Free Full Text]
|
| 35.
|
Egan, S.,
Cohen, B.,
Sarkar, M.,
Ying, Y.,
Cohen, S.,
Singh, N.,
Wang, W.,
Flock, G.,
Goh, T.,
and Schachter, H.
(2000)
Glycoconj. J.
17,
867-875[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Cole, S. E.,
Mao, M. S.,
Johnston, S. H.,
and Vogt, T. F.
(2001)
Mamm. Genome
12,
177-179[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Vollrath, B.,
Fitzgerald, K. J.,
and Leder, P.
(2001)
Mol. Cell. Biol.
21,
5688-5697[Abstract/Free Full Text]
|
| 38.
|
Griffitts, J. S.,
Whitacre, J. L.,
Stevens, D. E.,
and Aroian, R. V.
(2001)
Science
293,
860-864[Abstract/Free Full Text]
|
| 39.
|
Marroquin, L. D.,
Elyassnia, D.,
Griffitts, J. S.,
Feitelson, J. S.,
and Aroian, R. V.
(2000)
Genetics
155,
1693-1699[Abstract/Free Full Text]
|
| 40.
|
Dennis, R. D.,
Wiegandt, H.,
Haustein, D.,
Knowles, B. H.,
and Ellar, D. J.
(1986)
Biomed. Chromatogr.
1,
31-37[CrossRef][Medline]
[Order article via Infotrieve]
|
| 41.
|
Bremer, E. G.,
Schlessinger, J.,
and Hakomori, S.
(1986)
J. Biol. Chem.
261,
2434-2440[Abstract/Free Full Text]
|
| 42.
|
Miljan, E. A.,
Meuillet, E. J.,
Mania-Farnell, B.,
George, D.,
Yamamoto, H.,
Simon, H. G.,
and Bremer, E. G.
(2002)
J. Biol. Chem.
277,
10108-10113[Abstract/Free Full Text]
|
| 43.
|
Nojiri, H.,
Stroud, M.,
and Hakomori, S.
(1991)
J. Biol. Chem.
266,
4531-4537[Abstract/Free Full Text]
|
| 44.
|
Van Brocklyn, J.,
Bremer, E. G.,
and Yates, A. J.
(1993)
J. Neurochem.
61,
371-374[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. G. T. Hagen, L. Zhang, E Tian, and Y. Zhang
Glycobiology on the fly: Developmental and mechanistic insights from Drosophila
Glycobiology,
February 1, 2009;
19(2):
102 - 111.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ueyama, H. Takemae, Y. Ohmae, H. Yoshida, H. Toyoda, R. Ueda, and S. Nishihara
Functional Analysis of Proteoglycan Galactosyltransferase II RNA Interference Mutant Flies
J. Biol. Chem.,
March 7, 2008;
283(10):
6076 - 6084.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. R. Pigott and D. J. Ellar
Role of Receptors in Bacillus thuringiensis Crystal Toxin Activity
Microbiol. Mol. Biol. Rev.,
June 1, 2007;
71(2):
255 - 281.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Aoki, M. Perlman, J.-M. Lim, R. Cantu, L. Wells, and M. Tiemeyer
Dynamic Developmental Elaboration of N-Linked Glycan Complexity in the Drosophila melanogaster Embryo
J. Biol. Chem.,
March 23, 2007;
282(12):
9127 - 9142.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Fuller, T. Schwientek, H. H. Wandall, J. W. Pedersen, H. Clausen, and S. B. Levery
Structure elucidation of neutral, di-, tri-, and tetraglycosylceramides from High Five cells: identification of a novel (non-arthro-series) glycosphingolipid pathway
Glycobiology,
December 1, 2005;
15(12):
1286 - 1301.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Katic, L. G. Vallier, and I. Greenwald
New Positive Regulators of lin-12 Activity in Caenorhabditis elegans Include the BRE-5/Brainiac Glycosphingolipid Biosynthesis Enzyme
Genetics,
December 1, 2005;
171(4):
1605 - 1615.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. H. Wandall, S. Pizette, J. W. Pedersen, H. Eichert, S. B. Levery, U. Mandel, S. M. Cohen, and H. Clausen
Egghead and Brainiac Are Essential for Glycosphingolipid Biosynthesis in Vivo
J. Biol. Chem.,
February 11, 2005;
280(6):
4858 - 4863.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kohyama-Koganeya, T. Sasamura, E. Oshima, E. Suzuki, S. Nishihara, R. Ueda, and Y. Hirabayashi
Drosophila Glucosylceramide Synthase: A NEGATIVE REGULATOR OF CELL DEATH MEDIATED BY PROAPOPTOTIC FACTORS
J. Biol. Chem.,
August 20, 2004;
279(34):
35995 - 36002.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Griffitts, D. L. Huffman, J. L. Whitacre, B. D. Barrows, L. D. Marroquin, R. Muller, J. R. Brown, T. Hennet, J. D. Esko, and R. V. Aroian
Resistance to a Bacterial Toxin Is Mediated by Removal of a Conserved Glycosylation Pathway Required for Toxin-Host Interactions
J. Biol. Chem.,
November 14, 2003;
278(46):
45594 - 45602.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Correia, V. Papayannopoulos, V. Panin, P. Woronoff, J. Jiang, T. F. Vogt, and K. D. Irvine
Molecular genetic analysis of the glycosyltransferase Fringe in Drosophila
PNAS,
May 27, 2003;
100(11):
6404 - 6409.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Mitoma, B. Petryniak, N. Hiraoka, J.-C. Yeh, J. B. Lowe, and M. Fukuda
Extended Core 1 and Core 2 Branched O-Glycans Differentially Modulate Sialyl Lewis x-type L-selectin Ligand Activity
J. Biol. Chem.,
March 7, 2003;
278(11):
9953 - 9961.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. H. Wandall, J. W. Pedersen, C. Park, S. B. Levery, S. Pizette, S. M. Cohen, T. Schwientek, and H. Clausen
Drosophila egghead Encodes a beta 1,4-Mannosyltransferase Predicted to Form the Immediate Precursor Glycosphingolipid Substrate for brainiac
J. Biol. Chem.,
January 10, 2003;
278(3):
1411 - 1414.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|